Scancell Holdings (SCLP)


Latest News

Results of AGM

RNS Number: 8832M Scancell Holdings Plc 18 October 2016 18 th October 2016 Scancell Holdings Plc ("Scancell" or the "Company") Results of AGM Scancell Holdings Plc, (AIM:SCLP), the developer of novel immunotherapies for the treatment of cancer, announces that all resolutions proposed at the Annual General Meeting held today were duly passed. For Further In...

Preparing SCIB2 for clinical study in lung cancer

RNS Number: 0748M Scancell Holdings Plc 10 October 2016 10 October 2016 Scancell Holdings Plc ("Scancell" or the "Company") Scancell preparing SCIB2 for clinical study in lung cancer SCIB2 will be developed for the treatment of non-small cell lung cancer in combination with a checkpoint inhibitor Latest SCIB2 data published in peer-reviewed journal OncoImm...

Hardman Report: New frontiers in T-cell activation

RNS Number: 7395K Scancell Holdings Plc 26 September 2016 Hardman Research: New frontiers in T-cell activation New frontiers in T-cell activation and targeting: Scancell is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates hig...

Notice of AGM - Amendment

RNS Number: 7447K Scancell Holdings Plc 23 September 2016 23 September 2016 Scancell Holdings Plc Notice of AGM Amendment Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of cancer, will host its Annual General Meeting on Tuesday 18 October 2016. AGM details are as follows: Date: Tuesday 18 Octo...

All News

18-10-16Results of AGMRNS
10-10-16Preparing SCIB2 for clinical study in lung cancerRNS
26-09-16Hardman Report: New frontiers in T-cell activationRNS
23-09-16Notice of AGM - AmendmentRNS
23-09-16Scancell Holdings schedules AGMStockMarketWire
23-09-16Notice of AGMRNS
16-09-16Scancell widens H1 pretax loss StockMarketWire
16-09-16Final ResultsRNS
07-09-16NewsMakers in the Biotech Industry ConferenceRNS
22-08-16Appointment of Non-Executive DirectorRNS
21-07-16Eurogentec manufacturing agreementRNS
20-07-16Scancell extends Ichor commercial optionStockMarketWire
20-07-16Extension to Ichor Commercial OptionRNS
13-07-16Peer-reviewed publication on Moditope? platformRNS
06-07-16Scancell notes SCIB1 compelling survival data StockMarketWire
06-07-16SCIB1 compelling survival data in melanomaRNS
29-06-16Second Price Monitoring ExtnRNS
29-06-16Price Monitoring ExtensionRNS
17-06-16FTSE flies amid Brexit pause as gold, oil off highsStockMarketWire
17-06-16Scancell suspends dosing of SCIB1 immediatelyStockMarketWire
17-06-16SCIB1 Drug Product SupplyRNS
02-06-16Scancell updates on ImmunoBody vaccine StockMarketWire
02-06-16Development of ImmunoBody? VaccineRNS
18-05-16Broker Forecast - Panmure Gordon issues a broker note on Scancell Holdings PLCStockMarketWire
18-05-16Opens US Headquarters in San DiegoRNS
19-04-16Director/PDMR ShareholdingRNS
11-04-16Holding(s) in CompanyRNS
06-04-16Holding(s) in CompanyRNS
04-04-16Scancell raises total of GBP6.2mStockMarketWire
04-04-16Result of the open offerRNS
01-04-16Scancell updates on open offerStockMarketWire
01-04-16Result of open offerRNS
23-03-16World Cancer Vaccine CongressRNS
11-03-16FTSE, Europe rebounding on financials post ECBStockMarketWire
11-03-16Scancell collaborates with Karolinska Institutet StockMarketWire
11-03-16Strategic collaboration with Karolinska InstitutetRNS
11-03-16Posting of CircularRNS
09-03-16Scancell raises GBP3.4mStockMarketWire
09-03-16Placing and Open Offer CloseRNS
09-03-16Proposed Placing and Open OfferRNS

RSS feeds

  • Editorial news feed for LSE:SCLP Editorial
  • Regulatory news feed for LSE:SCLP Regulatory